2024-513439-25-00招募中1 期
A Phase 1 Study of JNJ-87562761 in Relapsed/Refractory Multiple Myeloma
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 15
- 试验地点
- 5
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
CTIS Point of Contact
Scientific
Janssen Cilag International
研究点 (5)
Loading locations...
相似试验
招募中
1 期
A Phase 1, First-in-human Study of JNJ-80948543, a T-cell Redirecting Antibody, in Participants with NHL and CLL2023-504187-42-00Janssen - Cilag International52
招募中
1 期
A Phase 1 Study of JNJ-87189401 Combined with JNJ-78278343 for Advanced Prostate Cancer2023-504063-17-00Janssen - Cilag International48
招募中
2 期
An Open Label Study of JNJ-68284528, Directed Against BCMA in Subjects with Multiple MyelomaMultiple Myeloma2023-506587-13-00Janssen - Cilag International56
已完成
1 期
Phase 1b study to evaluate MK 0482 for Relapsed/Refractory AML/CMML2023-503580-42-00Merck Sharp & Dohme LLC15
招募中
1 期
A Phase 1 Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms2024-513199-16-00Janssen Cilag International20